# Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS

Study · id `cardio:ct-nct03881943` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03881943](<https://clinicaltrials.gov/study/NCT03881943>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03881943

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT03881943. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2018-12-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT03881943, source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)
- Started: 2017-01 (actual) (ClinicalTrials.gov record NCT03881943, source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)
- Primary completion: 2018-12-21 (actual) (ClinicalTrials.gov record NCT03881943, source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)
- Completion: 2018-12-21 (actual) (ClinicalTrials.gov record NCT03881943, source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03881943, source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03881943-2019-03-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: Ticagrelor Monotherapy Compared to Aspirin Monotherapy in Patients With History of ACS
- Acronym: FMD\_ACS
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor 60 mg
- Intervention (Drug): Aspirin 100 MG Oral Tablet, Enteric Coated
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome (`cardio:pubmed-35387483`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4d80eaae1344d12954a727ba0b359aaf6c475aed5b3b0fb2ef9776734ef97de3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
